<- Go Home

TLC Vision Corporation

TLC Vision Corporation operates laser eye surgery centers in the United States and Canada. The company offers various vision correction procedures, such as Laser Epithelial Keratomileusis for people previously turned down for LASIK because of thin or unusually shaped corneas; Photorefractive Keratectomy for people with larger pupils, thin corneas, other corneal issues, and dry eyes; and Monovision for people who are growing older and wish to leave one eye slightly nearsighted while the other eye is fully treated for distance vision. It also provides other vision correction procedures that comprise Conductive Keratoplasty for people who are growing older and are seeking a technology that improves near vision and allows them to depend less on reading glasses; Implantable Collamer Lenses for people whose prescriptions fall outside the accepted range for laser refractive procedures, have extreme nearsightedness, and who may otherwise not be an ideal candidate for laser vision correction; and Phakic Intraocular Lens for people who are over 40 and whose prescriptions fall outside the accepted range for laser vision correction procedures, have extreme nearsightedness, and who may otherwise not be an ideal candidate for laser vision correction, such as LASIK. In addition, it offers Custom LASIK, a laser vision correction procedure; and Bladeless LASIK that uses a gentle laser to create a precise and uniform corneal flap. TLC Vision Corporation was formerly known as TLC Laser Eye Centers Inc. and changed its name to TLC Vision Corporation in May 2002. The company was founded in 1993 and is based in Mississauga, Canada.

Market Cap

$50.00

Volume

544.0K

Cash and Equivalents

$18.0M

EBITDA

$33.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$62.9M

Profit Margin

28.30%

52 Week High

$0.00

52 Week Low

$0.00

Dividend

N/A

Price / Book Value

0.00

Price / Earnings

-0.00

Price / Tangible Book Value

0.00

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$17.9M

Return on Equity

75.77%

Return on Assets

8.43

Cash and Short Term Investments

$18.0M

Debt

$124.7M

Equity

-$61.7M

Revenue

$222.2M

Unlevered FCF

$31.9M

Sector

Health Care Providers and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches